Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Elusive cancer killer’s deep-sea hideout discovered after a nearly 20-year hunt

28.10.2003


In 1984, HARBOR BRANCH scientists exploring deep waters off the Bahamas in one of the institution’s Johnson-Sea-Link submersibles discovered a small piece of sponge that harbored a chemical with a remarkable ability to kill cancer cells in laboratory tests. Despite almost two decades of searching, though, the group was never able to find enough of the sponge to fully explore its potential. But now that process can finally begin because, thanks to some creative detective work, the team has found the animal’s secret hiding place and collected enough of it to support years of intense research.


The Johnson-Sea-Link I submersible, used to collect the promising sponge
Credit: HARBOR BRANCH


Amy Wright,director of Harbor Branch Biomedical Marine Research (right) and Shirley Pomponi, Harbor Branch vice-president and director of research, aboard the R/V Seward Johnson II sorting samples after a drug discovery submersible dive.
Credit: HARBOR BRANCH



"It’s just amazing," says Amy Wright, director of HARBOR BRANCH Biomedical Marine Research, of the sponge she has been on a career-long quest to find. "This is our next cure, I know it’s our next cure."

A chemical produced within the sponge, which has not yet been given an official name, has proven in one test of cancer-fighting potential to be about 400 times more potent than Taxol®, a widely used treatment for breast and other forms of cancer. As important, preliminary experiments have also shown the compound to be fairly non-toxic to normal cells.


But the limited amount of the sponge initially collected was not enough to carry the team through the long process of developing a potential medical treatment, which involves careful study of exactly how a chemical kills cancer cells and of its chemical structure. "Since 1984 it has been on our target list for every dive," says Wright, who first studied the compound as a postdoctoral fellow at HARBOR BRANCH during the ’80s.

On various expeditions over the years, scientists found only tiny pieces of the sponge, then last year two slightly larger pieces, but still they did not have enough to do the required research. So, in preparation for a cruise this year to the Bahamas that ran from Oct. 9 through the 24th, Wright and her team used clues from where each piece had been collected to put together a profile of the habitat where it must live.

The technique worked perfectly, and on the first submersible dive targeting an area that fit the profile, they found the sponge. "You know, you have these hypotheses, but when it is actually there, it just floors you that the hypothesis worked," says Wright, "We were really excited. I was just dancing around."

The sponge was found in water over 1,000 feet deep in an area the researchers often refer to as the "dead zone," because it is generally characterized by bare rock and very low biodiversity. The sponge, which can grow to about the size of a softball, had eluded researchers for so long because they generally avoid this area in favor of exploring more diverse habitats.

Wright predicts that the quantity of the sponge collected on the expedition using the submersible should be enough to carry the team through the full multi-year drug discovery process, possibly even to the first phase of human trials. "I never thought I would see that much of the sponge ever," says Wright, "Now we have enough to move forward."

If the chemical continues to show promise as the research process progresses, it would eventually be licensed to a pharmaceutical company, which would take the compound through clinical trials. A key step before that could happen would be for HARBOR BRANCH and its collaborators to develop a method to sustainably produce the chemical without having to collect it from wild sponges, which would be both economically and ecologically unfeasible. Possible methods would be raising the sponge through aquaculture, producing it synthetically, or, if the chemical turns out to be produced by a microorganism within the sponge, raising cultures of that microorganism. The full process of turning the chemical into a commercially available cancer treatment would likely take more than a decade.

The mystery sponge’s hideout was found on an expedition to the Bahamas that covered some 1,300 miles and took the team throughout the island chain almost as far south as the Turks and Caicos Islands. For more information about this expedition as well as background articles on the team’s research, please visit HARBOR BRANCH’s online expedition site at: http://www.at-sea.org

HARBOR BRANCH has already patented nearly a hundred potential pharmaceuticals from the tens of thousands of the organisms the Biomedical Marine Research group has collected since the ’80s at sites around the globe. Several of these are in various stages of development as potential commercial drugs. Discodermolide, a compound produced by a deepwater sponge found in the Bahamas, is currently in the first phase of human trials as a cancer treatment.

Mark Schrope | EurekAlert!
Further information:
http://www.hboi.edu/

More articles from Life Sciences:

nachricht Bacteria as pacemaker for the intestine
22.11.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Corporate coworking as a driver of innovation

22.11.2017 | Business and Finance

PPPL scientists deliver new high-resolution diagnostic to national laser facility

22.11.2017 | Physics and Astronomy

Quantum optics allows us to abandon expensive lasers in spectroscopy

22.11.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>